Ery-Ped vs. its authorized generic and generics

How to pay the least

Ask for the cash price

Generic erythromycin ethylsuccinate

No pharmacy we check posts a price for it.

Ask your pharmacy for the cash price of generic erythromycin ethylsuccinate.Find pharmacies near you
Ask one or two other pharmacies too. Cash prices for the same generic can differ a lot from store to store.

A regular generic has the same active ingredient as Ery-Ped, and the FDA requires it to work the same way.

Compare every option

Brand nameEry-Ped

Authorized genericerythromycin ethylsuccinate

Regular genericerythromycin ethylsuccinate

What you’d pay

Cash priceAsk the pharmacyUsually the highest price

Cash priceAsk the pharmacyUsually among the lowest

Same as Ery-Ped?

The original

Same medicine

Same active ingredientFillers and dyes can differ

Brand nameNo maker’s card

We didn’t find a savings card or cash price from Ery-Ped’s maker. Ask the pharmacy for Ery-Ped’s cash price. With insurance, ask what your plan charges.

Authorized genericThe NDC to ask for

The same medicine as Ery-Ped, without the brand name. Give the pharmacy its NDC to get it.

erythromycin ethylsuccinate

Sold by

Wilshire Pharmaceuticals

Your strength

NDC to ask for

200 mg/5 mLsuspension
- 52536-132-1311-digit: 52536-0132-13100 mL per bottle
400 mg/5 mLsuspension
- 52536-130-1311-digit: 52536-0130-13100 mL per bottle

Source: FDA, updated October 30, 2026

What to say at the pharmacy

“Before you fill my Ery-Ped, can you tell me what I’d pay for the brand, for the authorized generic from Wilshire Pharmaceuticals, and for a regular generic?”

Paying cash? Ask for each one’s cash price. With insurance, ask what your plan charges for each.

Brand and authorized generic labels

Official labels and ingredient lists from DailyMed (U.S. National Library of Medicine).

400 mg/5 mL suspension

Same active and inactive ingredients as Ery-Ped.

Authorized generic package label from Wilshire Pharmaceuticals — Authorized genericWilshire Pharmaceuticals

See the ingredients

Active: erythromycin ethylsuccinate 400 mg/5 mL

Inactive, on both labels:

Caramel
Polysorbate 80
Sodium citrate
Sucrose
Xanthan gum

200 mg/5 mL suspension

Same active and inactive ingredients as Ery-Ped.

See the ingredients

Active: erythromycin ethylsuccinate 200 mg/5 mL

Inactive, on both labels:

Caramel
Polysorbate 80
Sodium citrate
Sucrose
Xanthan gum

Regular genericWho makes it

3 companies sell a generic of Ery-Ped that the FDA rates a substitute. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.

Amneal PharmaceuticalsSuspension 200 mg/5 mL, 400 mg/5 mL

How it looks, what’s in it, NDCs

200 mg/5 mL White to off-white granules

Package NDC
Bottle of 100 mL 60219-1503-1

200 mg/5 mL White to off-white granules

Package NDC
Bottle of 100 mL 69238-1503-1

400 mg/5 mL White to off-white granules

Package NDC
Bottle of 100 mL 60219-1504-2

400 mg/5 mL White to off-white granules

Package NDC
Bottle of 100 mL 69238-1504-2

Inactive ingredients: polysorbate 80, sucrose, xanthan gum, sodium citrate
FDA label
ANI PharmaceuticalsGranules 200 mg/5 mL, 400 mg/5 mL

Has lactose

Product page on anipharmaceuticals.com

How it looks, what’s in it, NDCs

200 mg/5 mL White

Package NDC
Bottle of 200 mL 62559-440-02

200 mg/5 mL White

Package NDC
Bottle of 100 mL 62559-630-01

400 mg/5 mL White

Package NDC
Bottle of 100 mL 62559-631-01

Inactive ingredients: anhydrous lactose, methylparaben, polysorbate 80, povidone k30, anhydrous trisodium citrate, sucrose, dimethicone, silicon dioxide
FDA label
Nivagen PharmaceuticalsSuspension 200 mg/5 mL, 400 mg/5 mL

Made by Cadila Pharmaceuticals

How it looks, what’s in it, NDCs

200 mg/5 mL Creamy to light brownish color

Package NDC
Bottle of 100 mL 75834-295-01

400 mg/5 mL Creamy to light brownish color

Package NDC
Bottle of 100 mL 75834-294-01

Inactive ingredients: caramel, sucrose, polysorbate 80, sodium citrate, xanthan gum
FDA label

Package	NDC
Bottle of 100 mL	60219-1503-1

Package	NDC
Bottle of 100 mL	69238-1503-1

Package	NDC
Bottle of 100 mL	60219-1504-2

Package	NDC
Bottle of 100 mL	69238-1504-2

Package	NDC
Bottle of 200 mL	62559-440-02

Package	NDC
Bottle of 100 mL	62559-630-01

Package	NDC
Bottle of 100 mL	62559-631-01

Package	NDC
Bottle of 100 mL	75834-295-01

Package	NDC
Bottle of 100 mL	75834-294-01

Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.

What it’s used for

What the FDA label says

To reduce the development of drug-resistant bacteria and maintain the effectiveness of Ery-Ped and other antibacterial drugs, Ery-Ped should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

Ery-Ped is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the diseases listed below:

Upper respiratory tract infections of mild to moderate degree caused by Streptococcus pyogenes, Streptococcus pneumoniae,or Haemophilus influenzae(when used concomitantly with adequate doses of sulfonamides, since many strains of H. influenzaeare not susceptible to the erythromycin concentrations ordinarily achieved). (See appropriate sulfonamide labeling for prescribing information.)

Lower-respiratory tract infections of mild to moderate severity caused by Streptococcus pneumoniaeor Streptococcus pyogenes.

Listeriosis caused by Listeria monocytogenes.

Pertussis (whooping cough) caused by Bordetella pertussis. Erythromycin is effective in eliminating the organism from the nasopharynx of infected individuals rendering them noninfectious. Some clinical studies suggest that erythromycin may be helpful in the prophylaxis of pertussis in exposed susceptible individuals.

Respiratory tract infections due to Mycoplasma pneumoniae.

Skin and skin structure infections of mild to moderate severity caused by Streptococcus pyogenesor Staphylococcus aureus(resistant staphylococci may emerge during treatment).

Diphtheria

Infections due to Corynebacterium diphtheriae, as an adjunct to antitoxin, to prevent establishment of carriers and to eradicate the organism in carriers.

Erythrasma

In the treatment of infections due to Corynebacterium minutissimum.

Intestinal amebiasis caused by Entamoeba histolytica(oral erythromycins only). Extraenteric amebiasis requires treatment with other agents.

Acute Pelvic Inflammatory Disease Caused by Neisseria gonorrhoeae

As an alternative drug in treatment of acute pelvic inflammatory disease caused by N. gonorrhoeaein female patients with a history of sensitivity to penicillin. Patients should have a serologic test for syphilis before receiving erythromycin as treatment of gonorrhea and a follow-up serologic test for syphilis after 3 months.

Syphilis Caused by Treponema pallidum

Erythromycin is an alternate choice of treatment for primary syphilis in penicillin-allergic patients. In primary syphilis, spinal fluid examinations should be done before treatment and as part of follow-up after therapy.

Erythromycins are indicated for the treatment of the following infections caused by Chlamydia trachomatis

Conjunctivitis of the newborn, pneumonia of infancy, and urogenital infections during pregnancy. When tetracyclines are contraindicated or not tolerated, erythromycin is indicated for the treatment of uncomplicated urethral, endocervical, or rectal infections in adults due to Chlamydia trachomatis.

When tetracyclines are contraindicated or not tolerated, erythromycin is indicated for the treatment of nongonococcal urethritis caused by Ureaplasma urealyticum.

Legionnaires' Disease caused by Legionella pneumophila. Although no controlled clinical efficacy studies have been conducted, in vitroand limited preliminary clinical data suggest that erythromycin may be effective in treating Legionnaires' Disease.

Prophylaxis

Prevention of Initial Attacks of Rheumatic Fever

Penicillin is considered by the American Heart Association to be the drug of choice in the prevention of initial attacks of rheumatic fever (treatment of Streptococcus pyogenesinfections of the upper respiratory tract, e.g., tonsillitis or pharyngitis). Erythromycin is indicated for the treatment of penicillin-allergic patients. 1The therapeutic dose should be administered for 10 days.

Prevention of Recurrent Attacks of Rheumatic Fever

Penicillin or sulfonamides are considered by the American Heart Association to be the drugs of choice in the prevention of recurrent attacks of rheumatic fever. In patients who are allergic to penicillin and sulfonamides, oral erythromycin is recommended by the American Heart Association in the long-term prophylaxis of Streptococcal pharyngitis (for the prevention of recurrent attacks of rheumatic fever). 1

Source: the FDA label for Ery-Ped (Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)), December 16, 2023. Full label on DailyMed

Good to know

It may look different from Ery-Ped (color, shape, or markings). That’s normal for an authorized generic.
If your prescription says “dispense as written,” the pharmacy needs your prescriber’s OK to give you the authorized generic.
Cash prices can differ a lot from one pharmacy to the next, so it can pay to ask two. With insurance, what you pay depends on your plan.
If your pharmacy doesn’t stock it, they can often order it within a day or two.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/ery-ped/